Working... Menu
Trial record 49 of 73 for:    "Paroxysmal Nocturnal Hemoglobinuria"

Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes (EXPLORE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01192425
Recruitment Status : Completed
First Posted : September 1, 2010
Last Update Posted : September 1, 2010
Information provided by:
Alexion Pharmaceuticals

Brief Summary:
Examine red and white blood cells of PNH patients with bone marrow failure syndromes.

Condition or disease

Layout table for study information
Study Type : Observational
Actual Enrollment : 5580 participants
Time Perspective: Prospective
Official Title: P06-001: (EX)Amination of (P)NH, by (L)Evel (O)f CD59 on (RE)d and White Blood Cells, in Bone Marrow Failure Syndromes

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   10 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients at least 10 years of age with aplastic anemia, myelodyplastic syndromes or other bone marrow failure syndromes.

Inclusion Criteria:

  • At least 10 years of age.
  • Has aplastic anemia, myelodysplastic syndromes or other bone marrow failure syndromes

Exclusion Criteria:

  • Has any condition that might interfere with the patient's participation

Layout table for additonal information
Responsible Party: Michael Bombara, Senior Director, Global Clinical Operations, Alexion Pharmaceuticals, Inc. Identifier: NCT01192425     History of Changes
Other Study ID Numbers: P06-001
First Posted: September 1, 2010    Key Record Dates
Last Update Posted: September 1, 2010
Last Verified: August 2010

Keywords provided by Alexion Pharmaceuticals:
PNH clone cells
Aplastic Anemia
Myelodysplastic Syndromes
bone marrow failure syndromes
Paroxysmal Nocturnal Hemoglobinuria

Additional relevant MeSH terms:
Layout table for MeSH terms
Hemoglobinuria, Paroxysmal
Anemia, Aplastic
Pathologic Processes
Urination Disorders
Urologic Diseases
Urological Manifestations
Signs and Symptoms
Anemia, Hemolytic
Hematologic Diseases
Myelodysplastic Syndromes
Bone Marrow Diseases